Navigate Up
UPMC/University of Pittsburgh Schools of the Health Sciences
Director
Telephone: 412-586-9777

Patients and medical professionals may call 1-800-533-UPMC (8762) for more information.
 

 

 

 

 

Our Experts

Jeffrey Romoff

Jeffrey Romoff
Biography

UPMC Media Relations

UPMC Joins Italian Government To Create $398 Million Biomedical Research Center In Sicily

PITTSBURGH, April 4, 2006 — Building on its successful transplant center and clinical facility in Palermo, Italy, the University of Pittsburgh Medical Center (UPMC) today announced a partnership with the Italian government, the Region of Sicily and Italy’s National Research Council to create a $398 million (€330 million) Biomedical Research and Biotechnology Center (BRBC), also to be located in Sicily.

Funded completely by the Italian government, the new center will be jointly managed by UPMC and the University of Pittsburgh School of Medicine. It will put Italy in the forefront of developing new drugs, vaccines, devices and other biomedical advances aimed at improving the health of its citizens and sparking economic development throughout the region.

“We have finalized all details in record time. In little more than 11 months, we have managed to find the necessary funds for what can become a financial and scientific resource for the entire Mediterranean Basin,” said Gianfranco Micciché, deputy minister for economic affairs and finance for Southern Italy, at a press conference today in Rome.

For their part, UPMC and the School of Medicine, which comprise one of the leading biomedical research and academic medical centers in the United States, will oversee operations of the center and its scientific programs, train researchers and staff and help to attract research funding and private investors to support rapid commercialization of the discoveries made there. “The benefits of this partnership will reach far beyond Italy. The scientific breakthroughs made here will improve health care around the world, while strengthening our leading research and clinical programs in Pittsburgh,” said Jeffrey A. Romoff, president of UPMC. “As we’ve already proven in Palermo, we have a unique ability to export our best clinical and scientific practices to our international partners.”

The BRBC, expected to open by 2010, will focus on five of the most important areas in biomedical research: drug discovery, vaccine development, tissue engineering and regenerative medicine, molecular imaging, and computational and structural biology. No other center in Italy will match the BRBC’s size and scope. When fully operational, it is expected to employ more than 600 scientists on a campus that may eventually include a new hospital and medical school. The Italian center will complement the University of Pittsburgh’s world-class research being conducted in these same areas.

“Together with our Italian colleagues, who are considered among the best scientific minds today, we can exponentially increase our ability to address the most challenging and complex questions in biomedical research,” said Arthur S. Levine, M.D., senior vice chancellor, health sciences, and dean of the medical school. “There are simply many more scientific questions to be addressed than any one center can possibly address by itself.” The BRBC is expected to develop research partnerships with other Italian centers, as well as European and American scientists interested in the same lines of research.

For UPMC, the center is part of an international expansion effort that provides new revenue to support its core medical mission. In partnership with the Region of Sicily, UPMC in 1997 established the Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT) to offer organ transplantation and advanced medical treatments in this underserved region. ISMETT, which opened its new facility in 2004, is expected to perform more than 120 transplants of livers, kidneys, hearts and other organs this year. UPMC also will open two cancer treatment centers in Ireland later this year, building on its reputation as a leader in cancer care.

Leveraging relationships with major companies, such as IBM and General Electric, UPMC will help the BRBC move promising research quickly from the lab to the marketplace, just as it’s done in western Pennsylvania. The University of Pittsburgh and UPMC also have strong ties to venture capital firms in the U.S. and Europe, which could help to fuel the development of new biotechnology companies and a venture capital industry in Sicily.

Construction of the BRBC, to be located between the towns of Carini and Cinisi, will begin in 2007. The Italian government has budgeted €330 million over five years for construction and startup costs. Planning for the center began in 2005 after the Italian government and UPMC saw the positive results of their public-private partnership at the Palermo transplant center. A new foundation, called Ri.Med, has been created to provide continuing support and oversight of the BRBC. The foundation consists of five partners: the Italian government, the Region of Sicily, the National Research Council, the University of Pittsburgh and UPMC. Paolo Pucci di Benischi, secretary general of the Foreign Affairs Ministry, is the foundation’s president.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com